VP Clinical Research
Adagio Therapeutics
Disclosure(s): Adagio Therapeutics: Employee, Stocks/Bonds
Dr. Pete Schmidt, MD MSc is the Vice President of Clinical Research at Adagio Therapeutics where he oversees Phase I-III clinical studies of Adagio's monoclonal antibody programs. He is also an Assistant Clinical Professor at Stanford University, Department of Anesthesiology, Division of Pain Medicine where he focuses on the treatment of cancer-associated pain.